Newsletter | August 18, 2026

08.18.26 -- Reassessing Nanoparticle Immunotoxicity Testing Methods

Webinar: Characterizing Process Performance and Robustness in an End-to-End Cryopreserved Autologous CAR-T/TCR Workflow

Learn how to improve consistency and scalability in autologous CAR-T manufacturing. This CARR Biosystems webinar explores how critical process parameters impact cell health, viability, recovery, and reproducibility across an end-to-end workflow using cryopreserved leukopaks. Gain practical strategies to reduce variability, optimize closed-system processing, and support efficient clinical and commercial cell therapy manufacturing with integrated technology solutions. Click here to learn more.

FOCUS ON MANUFACTURING

Reassessing Nanoparticle Immunotoxicity Testing Methods

This article highlights government-funded resources available to de-risk nanomedicines, reviews principles of immunotoxicity testing, and discusses emerging methodologies.

Digital Twin For Fill-Finish: An Overview And Use Cases

Digital twin technology optimizes aseptic fill-finish through real-time mirroring and predictive simulation. Improve yields and validate complex recipes by integrating dynamic virtual models.

Controlling Nucleic Acid Impurities In Viral Vector Processing

Achieving high-quality viral vectors demands rigorous control over contaminants. Learn about enzymatic approaches to significantly reduce nucleic acid impurities in your manufacturing processes.

Evaluating Membrane Filtration For High Microbial Recovery

Compare membrane materials and pore sizes to assess their impact on flow rate and microbial recovery. See how fast filtration and ≥90% organism recovery offer guidance for selecting reliable membranes.

Manifolding For Scale-Up, Safety, And Speed

The use of manifolds to fill bags for bioprocessing or advanced therapies contributes to time savings, improved process quality, and optimal use of cleanroom and personnel resources.

Scalable rAAV9 Production Using Advanced Cell Lines And Bioreactors

High-density cell growth and robust bioprocessing push gene therapy development forward. Explore techniques that smoothly transition viral vector cultures from bench to full scale.

Addressing The Challenges In Lentivirus Harvest Clarification

Traditional depth filtration struggles with lentiviral harvest clarification, leading to low yields and high costs. However, single-use centrifugation offers a promising alternative.

Mitigating Manufacturing Risks In Large-Scale MSC Therapies

Achieve scalable MSC manufacturing by implementing closed systems and modular scale-out strategies that minimize contamination risks and ensure consistent cellular stability and efficacy.

Optimizing And Scaling Lentiviral Vector Production

Upstream and downstream vector production benefits from systematic process refining. See how design of experiments methodology elevates output across all stages of manufacturing.

The Power Of 3: How Triple Stack Incubators Can Help Optimize Your Lab

Maximize your lab’s efficiency without sacrificing space; triple-stack incubators help scale operations, run multiple experiments, and streamline workflows within a compact footprint.

Release By Exception Saves Time And Money In QC Activities

Release by exception reduces the manpower needed for reviewing QC batch information, only requiring quality teams to review information when predefined targets are not met and lowering costs.

Chemically Defined Medium For Intensified AAV And LV Production In HEK293 Cells

Purpose-built chemically defined media supports intensified AAV and LV perfusion cultures, achieving viable HEK293 cell densities above 10^8 cells/mL for improved overall productivity.

SPONSOR

Webinar: Evolving Lentiviral Vector Manufacturing with Stable Production

As in vivo lentiviral programs expand, manufacturers need scalable, reliable production platforms that deliver consistent quality. Join Asimov's Sybil Danby and Adam Carcella to explore next-generation LV manufacturing strategies, including producer and packaging cell lines, and learn how synthetic biology and computational modeling are improving titer, reducing variability, and accelerating development for both ex vivo and in vivo therapies. Click here to learn more.

MANUFACTURING SOLUTIONS

High-Precision Automated Fill & Finish Workstation - CellBri

Seamless Transfer System With Built-In Sterilization - Esco Lifesciences

Streamline Fluid Disconnections And Reduce Tear-Down Complexity - CPC Biotech

Cell Culture Isolator System - TEMA SINERGIE

Contamination Control Products For Cell and Gene Therapy - Contec, Inc.

Implementing Scalable Training Excellence In CGT Manufacturing - Miltenyi Biotec

Nanoplasmid Vector Platform - Aldevron

Connect With Cell & Gene: